RECRUITING

Harm Reduction for Smokers With Mental Illness

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To compare the efficacy of e-cigarette (e-cig) provision with or without behavioral support (SWITCH IT) delivered via telehealth to reduce harm among smokers with MI who cannot quit smoking and are not ready to pursue cessation treatment, and to examine self-regulation (using e-cigs instead of cigarettes to cope with stress/distress and self-efficacy) as a potential mechanism for behavior change from SWITCH IT

Official Title

Harm Reduction for Smokers With Mental Illness: RCT of E-cigarette Provision With or Without Behavioral Support to Boost Switching

Quick Facts

Study Start:2024-10-01
Study Completion:2028-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06543407

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 21 years or older;
  2. * English-speaking;
  3. * Daily smoker (at least 10 cigarettes/day);
  4. * At least one quit attempt in the past 5 years using evidence- based pharmacotherapy or behavioral cessation support;
  5. * Not currently interested in quitting.
  1. * Currently residing in a nursing home;
  2. * Current diagnosis of Asthma;
  3. * Cognitive impairment (score \<26 on the Telephone Interview for Cognitive Status (TICS);
  4. * Current use of e-cigarettes (\>once a week);
  5. * Psychiatric instability (hospitalized in the past month);
  6. * Current AND moderate to severe substance use disorder;
  7. * Pregnant or planning to become pregnant;
  8. * Use of any smoked products other than cigarettes;
  9. * Current unstable medical illness making e-cigarette unsafe (e.g., recent heart attack, cancer);
  10. * Participation in SWITCH IT pilot study.

Contacts and Locations

Study Contact

Meghan M. Santos, MSW
CONTACT
978-494-4260
meghan.m.santos@hitchcock.org
Gail Williams, MS, MFT
CONTACT
gail.williams@dartmouth.edu

Principal Investigator

Sarah I. Pratt, PhD
PRINCIPAL_INVESTIGATOR
Dartmouth Health

Study Locations (Sites)

Seven Counties Services
Louisville, Kentucky, 40203
United States
Homer Stryker MD School of Medicine (WMed)
Kalamazoo, Michigan, 49008
United States

Collaborators and Investigators

Sponsor: Dartmouth-Hitchcock Medical Center

  • Sarah I. Pratt, PhD, PRINCIPAL_INVESTIGATOR, Dartmouth Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-01
Study Completion Date2028-03-31

Study Record Updates

Study Start Date2024-10-01
Study Completion Date2028-03-31

Terms related to this study

Keywords Provided by Researchers

  • serious mental illness
  • harm reduction
  • e-cigarettes

Additional Relevant MeSH Terms

  • Tobacco Dependence